Accelerating AAV Vectors for CNS Disorders
Time: 4:30 pm
day: Day One
Details:
• Review current serotypes that can be applied in neurological disorders
• Capturing the methods to improve transduction efficiency
• Current status of enabling AAV to cross BBB